Alibaba prepares for imminent IPO at $68 per share
The fervor and suspense surrounding Alibaba's IPO roadshow has reached such a fever pitch that CNBC even quipped "it's like Alibaba cures cancer or something."
An inevitable result is that some expectations simply won't be met given how high expectations have risen for what is being flaunted as the greatest tech (or just general) initial public offering in history.
